ArticleJournal of investigative medicine high impact case reports

First-Line Use of Vemurafenib to Enable Thyroidectomy and Radioactive Iodine Ablation for BRAF-Positive Metastatic Papillary Thyroid Carcinoma: A Case Report.

Bao D Dao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.